BAFF, inhibitors thereof and their use in the modulation of B-cell response
US6869605B2 · kind B2 · utility
32Cited by
8References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 24, 2001 |
| Grant date | Mar 22, 2005 |
| Priority date | — |
| Expiry date | Jul 24, 2021 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/505
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides methods for treating or preventing disorders associated with expression of BAFF comprising BAFF and fragments thereof, antibodies, agonists and antagonists.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.